Quentin Pascal
Overview
Explore the profile of Quentin Pascal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
466
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Romeo P, Conquet L, Messiaen S, Pascal Q, Moreno S, Bravard A, et al.
Antioxidants (Basel)
. 2024 Sep;
13(9).
PMID: 39334742
Few therapeutic options are available to treat COVID-19. The KEAP1/NRF2 pathway, the major redox-responsive pathway, has emerged as a potential therapeutic target for COVID-19 as it regulates redox homeostasis and...
2.
Egloff C, Fovet C, Denis J, Pascal Q, Bossevot L, Luccantoni S, et al.
Virol J
. 2024 Sep;
21(1):209.
PMID: 39227837
Background: Early pregnancy Zika virus (ZIKV) infection is associated with major brain damage in fetuses, leading to microcephaly in 0.6-5.0% of cases, but the underlying mechanisms remain largely unknown. Methods:...
3.
Lemdani K, Marlin R, Mayet C, Perkov V, Pascal Q, Ripoll M, et al.
NPJ Vaccines
. 2024 Jun;
9(1):113.
PMID: 38902327
The characterization of vaccine distribution to relevant tissues after in vivo administration is critical to understanding their mechanisms of action. Vaccines based on mRNA lipid nanoparticles (LNPs) are now being...
4.
Galhaut M, Lundberg U, Marlin R, Schlegl R, Seidel S, Bartuschka U, et al.
Commun Med (Lond)
. 2024 Apr;
4(1):62.
PMID: 38570605
Background: The fight against COVID-19 requires mass vaccination strategies, and vaccines inducing durable cross-protective responses are still needed. Inactivated vaccines have proven lasting efficacy against many pathogens and good safety...
5.
SARS-CoV-2-related bat virus behavior in human-relevant models sheds light on the origin of COVID-19
Temmam S, Montagutelli X, Herate C, Donati F, Regnault B, Attia M, et al.
EMBO Rep
. 2023 Mar;
24(4):e56055.
PMID: 36876574
Bat sarbecovirus BANAL-236 is highly related to SARS-CoV-2 and infects human cells, albeit lacking the furin cleavage site in its spike protein. BANAL-236 replicates efficiently and pauci-symptomatically in humanized mice...
6.
Marlin R, Desjardins D, Contreras V, Lingas G, Solas C, Roques P, et al.
Nat Commun
. 2022 Aug;
13(1):5108.
PMID: 36042198
The COVID-19 pandemic has exemplified that rigorous evaluation in large animal models is key for translation from promising in vitro results to successful clinical implementation. Among the drugs that have...
7.
Roques P, Fritzer A, Dereuddre-Bosquet N, Wressnigg N, Hochreiter R, Bossevot L, et al.
JCI Insight
. 2022 Jun;
7(14).
PMID: 35700051
Chikungunya virus (CHIKV) is a reemerging mosquito-borne alphavirus responsible for numerous outbreaks. Chikungunya can cause debilitating acute and chronic disease. Thus, the development of a safe and effective CHIKV vaccine...
8.
Zabaleta N, Bhatt U, Herate C, Maisonnasse P, Sanmiguel J, Diop C, et al.
Mol Ther
. 2022 May;
30(9):2952-2967.
PMID: 35546782
The COVID-19 pandemic continues to have devastating consequences on health and economy, even after the approval of safe and effective vaccines. Waning immunity, the emergence of variants of concern, breakthrough...
9.
Naninck T, Kahlaoui N, Lemaitre J, Maisonnasse P, De Mori A, Pascal Q, et al.
iScience
. 2022 Mar;
25(4):104101.
PMID: 35313622
Non-human primates (NHPs) are particularly relevant as preclinical models for SARS-CoV-2 infection and nuclear imaging may represent a valuable tool for monitoring infection in this species. We investigated the benefit...
10.
Lipskaia L, Maisonnasse P, Fouillade C, Sencio V, Pascal Q, Flaman J, et al.
Am J Respir Cell Mol Biol
. 2021 Oct;
66(1):107-111.
PMID: 34648725
No abstract available.